Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2007-05-08
2007-05-08
Lukton, David (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S506000, C546S048000, C546S301000, C536S026110
Reexamination Certificate
active
10851096
ABSTRACT:
The present invention relates to the field of prodrugs of chemotherapeutic agents and method of use thereof.
REFERENCES:
patent: 4009283 (1977-02-01), Herr et al.
patent: 4053638 (1977-10-01), Litchfield et al.
patent: 4083974 (1978-04-01), Turi
patent: 4206220 (1980-06-01), Sloan
patent: 4412994 (1983-11-01), Sloan
patent: 4439451 (1984-03-01), Coleman
patent: 4443476 (1984-04-01), Lomen
patent: 4473584 (1984-09-01), Heckler
patent: 4477468 (1984-10-01), Heckler
patent: 4489080 (1984-12-01), Lomen
patent: 4613505 (1986-09-01), Mizushima et al.
patent: 4767751 (1988-08-01), Davis
patent: 4786495 (1988-11-01), Bird et al.
patent: 4897417 (1990-01-01), Patil et al.
patent: 4935508 (1990-06-01), Kamachi et al.
patent: 4937253 (1990-06-01), Gleason et al.
patent: 4990499 (1991-02-01), Gupta et al.
patent: 5196438 (1993-03-01), Martin et al.
patent: 5482965 (1996-01-01), Rajadhyaksha
patent: 5501863 (1996-03-01), Rossling et al.
patent: 5578637 (1996-11-01), Lai et al.
patent: 5614549 (1997-03-01), Greenwald et al.
patent: 5650510 (1997-07-01), Webb, II et al.
patent: 5654466 (1997-08-01), Stuk et al.
patent: 5681964 (1997-10-01), Ashton et al.
patent: 5707984 (1998-01-01), Tjoeng et al.
patent: 5712400 (1998-01-01), Leanna et al.
patent: 5714148 (1998-02-01), Burke et al.
patent: 5847003 (1998-12-01), Ptchelintsev et al.
patent: 5880131 (1999-03-01), Greenwald et al.
patent: 5918568 (1999-07-01), Gjerlov
patent: 6110908 (2000-08-01), Guthery
patent: 1 148 165 (1981-03-01), None
patent: 0 357 495 (1990-03-01), None
patent: 0 494 370 (1991-11-01), None
patent: 0 540 751 (1992-05-01), None
patent: WO96/22303 (1996-01-01), None
patent: WO00/77020 (2000-06-01), None
Cynkowski et al.—Novel prodrug ester forms of hydroxyl-containing drugs. Mono- and dicarboxylic oxa acids conjugates—Book of Abstracts, 211th ACS National Meeting, New Orleans, LA, Mar. 24-28 1996, MEDI-029 Publisher: American Chemical Society.
Monkhouse et al.—Transdermal Drug Delivery—Problems and Promises 0 Drug Development and Industrial Pharmacy, 14(2&3), 1983-209 (1988).
Stoughton et al.—Azone® : A New Non-toxic Enhancer of Cutaneous Penetration -Drug Development and Industrial Pharmacy, ((4), 723-744 (1983).
Wells et al.—Mutagenicity and Cytotoxicity of N-Methyl-2-pyrrolidinone and 4-(Methylamino)butanoic Acid inSalmonella/Microsome Assay—Journal of Applied Toxicology, vol. 8(2), 135-139 (1988).
Akhter et al.—Absorption through human skin of ibuprofen an dflubiprofen; effect of doese variation, deposited drug films, occlusion and the penetration enhancer N-methyl-2-pyrrolidone—J. Pharm. Pharmacol. 1985, 37: 27-37.
Hoelgaard, et al.—Vehicle effect on topical drug delivery IV. Effect of N-methylpyrrolidone and polar lips on percutaneous drug transport—International Journal of Pharmaceutics, 43 (1988) 233-240.
Bennett, et al.—Optimization of bioavailiability of topical steriods: non-occluded penetration enhancers under thermodynamic control—J. Pharm. Pharmacol. 1985, 37: 298-304.
Sasaki et al.—Enhancing effect of pyrrolidone derivatives on transdermal drug delivery. I.—International Journal of Pharmaceutics, 44 (1988) 15-24.
Cynkowski et al.—Novel prodrug ester forms of hydroxyl-containg drugs. Mono- and dicarboxylic oxa acids conjugates—Book of Abstracts, 211th ACS National Meeting, New Orleans, Mar. 24-28 1996, MEDI-029 Publisher: American Chemical Society.
Flynn—Mechanism of Percutaneous Absorption from Physicochemical Evidence—University of Michigan College of Pharmacy, pp. 17-42.
Wells et al.—Disposition and Metabolism of Double-Labeled [3H and14C] N-Methyl-2-Pyrrolidinone in the Rat—vol. 16, No. 2, 1988 The American Society for Pharmacology and Experimental Therapeutics.
Barry, et al.—Optimization of Bioavailability of Topical Steroids: Penetration Enhancers Under Occlusion—vol. 82, No. 1, The Journal of Investigation Dermatology, 82:49-52, 1984.
Sugibayashi, et al.—Effect of Several Penetration Enhancers on the Percutaneous Absorption of Indomethacin in Hairless Rats—Chem. Pharm. Bull. 36(4)1519-1528 (1988).
Chromey et al.—Toxicity of N-Methyl-2-pyrrolidone (NMP): Teratogenic, subchronic and Two-Year Inhalation Studies—Fundamental and Applied Toxicology 9, 222-235 (1987).
Cynkowska et al.—Structure-stability study of novel anti-HIV prodrugs of zalcitabine with acids, oxa acids and aminooxa acid derivatives—Book of Abstracts, 217th ACS National Meeting, Anaheim, Calif., Mar. 21-25 , 1999, MEDI-170 Publisher: American Chemical Society.
Cynkowski, et al.—Synthesis and properties of novel codrugs of protease inhibitors with reverse transcriptase inhibitors—Book of Abstracts, 217th ACS National Meeting, Anaheim, CA, Mar. 21-25, 1999, MEDI-171, Publisher—American Chemical Society.
Cynkowska, et al.—Synthesis and propertis of biolabile prodrugs of zidovudine with polyoxa acids and short chain polyethylene glycols—Abstracts of Papers American Chemical Society, (1998) Vo. 215, No. 1-2, pp. MEDI 36.
Cynkowska, et al.—Synthesis and properties of biolabile prodrugs of didanosine with polyoxa acids, amino acids and short chain polyethylene glycols—Book of Abstracts, 216th ACS National Meeting, Boston, Aug. 23-27, 1998, MEDI-347 Publisher: American Chemical Society.
Greenwald, et al.—Camptothecin-20-PEG ester transport forms: the effect of spacer groups on antitumor activity—Bioorg. Med. Chem *1998), 6(5), 551-562.
Ashton Paul
Crooks Peter A.
Cynkowska Grazyna
Cynkowski Tadeusz
Guo Hong
Lukton David
McDermott Will & Emery LLP
University of Kentucky Research Foundation
LandOfFree
Permeable, water soluble, non-irritating prodrugs of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Permeable, water soluble, non-irritating prodrugs of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Permeable, water soluble, non-irritating prodrugs of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3735803